ESMO 2017 | What have we learned from recent clinical trials in early breast cancer treatment?

Although there has been a lack of practice-changing new data for the treatment of early breast cancer, there have been many studies which examined the efficacy of novel agents and strategies. Elzbieta Senkus-Konefka, MD, PhD from the Medical University of Gdansk, Gdansk, Poland talks to us about some of these studies, including the PEARL study (NCT02028507) and the LORELEI study (NCT02273973), and offers her opinion on the results achieved. This study was recorded at the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain.